Prentiss Smith & Co’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
Prentiss Smith & Co's QGEN Position: Q2 2026 in Review
Prentiss Smith & Co reduced its Qiagen (QGEN) stake by 1.3% in Q2 2026, selling an estimated $61.9K and leaving 131,596 shares worth $5.15M. The position accounts for 2.82% of the portfolio, ranked #12.
Prentiss Smith & Co first reported a position in QGEN in Q1 2020 and has held it in 9 quarters since. The position peaked at $5.34M in Q1 2026. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- Prentiss Smith & Co held 131,596 shares of Qiagen worth $5.15M as of Q2 2026.
- Prentiss Smith & Co sold 1,668 Qiagen shares in Q2 2026, an estimated $61.9K.
- Qiagen made up 2.82% of Prentiss Smith & Co's portfolio in Q2 2026, its #12 holding.
- Prentiss Smith & Co first reported a position in Qiagen in Q1 2020 and has held it in 9 quarters since.
- Prentiss Smith & Co's Qiagen position peaked at $5.34M in Q1 2026.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on Prentiss Smith & Co's 13F filing for Q2 2026, filed 30 Jul 2026.